NEULANDLAB logo

Neuland LAB LTD.

NEULANDLAB·NSE·
23,035.00 +25.00 (+0.11%)
Market Cap29531.75 Cr
PE Ratio81.19
Volume29,733
Day High - Low23185.00 - 22710.00
52W High-Low23881.00 - 11500.00
DocStoX Score
6.9/10
Fair
Fair Value
Sign in to see
ROE
21.40%
Strong
P/E
81.19x
Expensive
Debt / Equity
0.16
Low
Industry
Healthcare
Pharmaceuticals
Overall View
Mixed

Price performance

NIFTY 500NIFTY SMALLCAP 250
Day22710
23185
52W11500
23881
DocStoX take

Supported by growth (9.1) and risk (8.9), but held back by valuation (0.0). Growth looks strong at 9.1, but that is offset by valuation at 0.0. We are calling it Mixed rather than resolving the conflict for you.

DocStoX score

Low confidence
6.9
/10
Fair
Quality
Excellent
ROE 21.4%
Valuation
Expensive
P/E 81.2×
Growth
Strong
Revenue +16.6% 5Y CAGR
Risk
Low risk
D/E 0.16
Momentum
Strong
93% of 52-week range

At a glance

Market Cap
₹29,532 Cr
52W High / Low
₹23881 / ₹11500
Dividend Yield
0.14%
Promoter Holding
32.62%
EPS (TTM)
₹283.71
Book Value
₹1461.00

Key highlights

  • Profit compounding 35% a year
  • Low leverage — D/E 0.16
  • Profitable in all of the last 5 years
  • Valuation is weak (0.0/10)
  • Expensive at 81× earnings
4 Positives2 Watchouts

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.

More Healthcare stocks · Pharmaceuticals

NEULAND LAB LTD. peers in Healthcare

Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.